You can buy or sell PhaseBio and other stocks, options, ETFs, and crypto commission-free!
PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. Read More The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.
52 Week High
52 Week Low
Guru FocusMar 6
PhaseBio to Present at Cowen and Company 39th Annual Health Care Conference
MALVERN, Pa. and SAN DIEGO, March 06, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. ( PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, today announced that Chief Executive Officer Jonathan P. Mow will present a company overview at the Cowen and Company 39th Annual Health Care Conference on Wednesday, March 13, at 10:40 a.m. EDT in Boston. A live and archived version of the presentation will be available on...
-$0.31 per share
Available Mar 26, After Hours